The use of cell separation techniques and isantibody to host antigens in the treatent of severe combined immunodeficiency disease with HL-A incompatible maternal marrow.
D000937:Antigen-Antibody Reactions; D001853:Bone Marrow / Q000276:immunology; D001854:Bone Marrow Cells; D016026:Bone Marrow Transplantation; D002455:Cell Division; D002469:Cell Separation / Q000379:methods*; D002478:Cells, Cultured; D005260:Female; D006087:Graft vs Host Reaction; D006649:Histocompatibility Antigens; D006801:Humans; D007106:Immune Sera; D007114:Immunization; D007122:Immunoelectrophoresis; D007153:Immunologic Deficiency Syndromes / Q000628:therapy*; D007231:Infant, Newborn; D007518:Isoantibodies / Q000627:therapeutic use*; D037102:Lectins; D017710:Lymphocyte Transfusion; D008214:Lymphocytes / Q000276:immunology; D008297:Male; D011247:Pregnancy; D014184:Transplantation, Homologous
D006649:Histocompatibility Antigens; D007106:Immune Sera; D007518:Isoantibodies; D037102:Lectins